Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 6/2005

01.11.2005 | Original Article

Insufficiency risk of esophagojejunal anastomosis after total abdominal gastrectomy for gastric carcinoma

verfasst von: L. Meyer, F. Meyer, H. Dralle, M. Ernst, H. Lippert, I. Gastinger, East German Study Group for Quality Control in Operative Medicine and Regional Development in Surgery

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 6/2005

Einloggen, um Zugang zu erhalten

Abstract

Background

The outcome and quality of surgical treatment in gastric cancer are closely associated with specific postoperative morbidity and mortality, in addition to an oncosurgically adequate resection status. In this context, a preventive concept of decreasing the insufficiency rate of esophageal anastomosis may have a great impact.

Method

Over a time period of 12 months (from 1 January 2002 to 31 December 2002), 1,199 patients (from 80 East German hospitals) with gastric carcinoma, carcinoma of the esophagogastral junction, or gastrointestinal stroma tumor (GIST) were enrolled in this prospective multicenter observational study with the aim of evaluating their early postoperative outcome. By means of a logistic regression analysis, independent variables, which alter significantly the healing of esophagojejunal anastomosis, were determined; in addition, their clinical impact on preventive management to lower the insufficiency rate of esophageal anastomosis was investigated.

Results

In 1,139 patients, histological investigation revealed gastric carcinoma. Out of these patients, 1,031 subjects underwent surgical intervention (90.5%) and 891 individuals underwent resection (86.4%). In 813 patients, radical resection (subtotal resection and gastrectomy) was executed (78.9%), whereas in 726 cases, R0 resection was achieved (81.5%). Gastrectomy was the preferred procedure in 649 patients, resulting in a gastrectomy rate of 62.9% relating to all patients who underwent operation (curative and palliative intention, 80.3% and 19.7%, respectively). The insufficiency rate of esophagojejunal anastomosis was 5.7% (37/649). Neither the comparison between the various procedures for the reconstruction of the esophagojejunal passage and anastomosing techniques after gastrectomy nor that between gastrectomies with curative and palliative intention revealed any significant difference. Dysphagia and gastric outlet syndrome due to a stenosis were determined as independent variables by a logistic regression analysis of all preoperative and intraoperative variables. In all patients with gastric carcinoma, both parameters were recorded in 9.9% (113/1,139) and 6.7% (76/1,139), respectively.

Conclusion

Dysphagia and gastric stenosis, which significantly influence the healing of esophagojejunal anastomosis after gastrectomy, are considered characteristics of an advanced tumor growth and a pretherapeutic lack of an adequate nutrition. This emphasizes the necessity of an early diagnosis of gastric cancer in order to lower perioperative morbidity. In addition, dysphagia is commonly associated with an obstruction of the upper gastrointestinal tract, which can lead to nutritional deficits, and thus deserves specific care during preventive management.
Literatur
1.
Zurück zum Zitat Bollschweiler E, Böttcher K, Hölscher AH, Sasako M, Kinoshita T, Maruyama K, Siewert JR (1993) Is the prognosis for Japanese and German patients with gastric cancer really different? Cancer 71:2918–2925PubMed Bollschweiler E, Böttcher K, Hölscher AH, Sasako M, Kinoshita T, Maruyama K, Siewert JR (1993) Is the prognosis for Japanese and German patients with gastric cancer really different? Cancer 71:2918–2925PubMed
2.
Zurück zum Zitat Roder JD, Böttcher K, Siewert JR, Busch R, Hermanek P, Meyer HJ, German Gastric Carcinoma Study Group (1993) Results of the German Gastric Carcinoma Study 1992. Cancer 72:2089–2097PubMed Roder JD, Böttcher K, Siewert JR, Busch R, Hermanek P, Meyer HJ, German Gastric Carcinoma Study Group (1993) Results of the German Gastric Carcinoma Study 1992. Cancer 72:2089–2097PubMed
3.
Zurück zum Zitat Degiuli M, Sasako M, Ponti A, Calvo F (2004) Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 90:1727–1732PubMed Degiuli M, Sasako M, Ponti A, Calvo F (2004) Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 90:1727–1732PubMed
4.
Zurück zum Zitat Edwards P, Blackshaw GR, Lewis WG, Barry JD, Allison MC, Jones DR (2004) Prospective comparison of D1 vs. modified D2 gastrectomy for carcinoma. Br J Cancer 90:1888–1892PubMed Edwards P, Blackshaw GR, Lewis WG, Barry JD, Allison MC, Jones DR (2004) Prospective comparison of D1 vs. modified D2 gastrectomy for carcinoma. Br J Cancer 90:1888–1892PubMed
5.
Zurück zum Zitat Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22:2069–2077PubMed Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22:2069–2077PubMed
6.
Zurück zum Zitat McCulloch P, Ward J, Tekkis PP, ASCOT Group of Surgeons, British Oesophago-Gastric Cancer Group (2003) Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ 327:1192–1197CrossRefPubMed McCulloch P, Ward J, Tekkis PP, ASCOT Group of Surgeons, British Oesophago-Gastric Cancer Group (2003) Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ 327:1192–1197CrossRefPubMed
7.
Zurück zum Zitat Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K (2004) Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy—Japan Clinical Oncology Group study 9501. J Clin Oncol 22:2767–2773PubMed Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K (2004) Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy—Japan Clinical Oncology Group study 9501. J Clin Oncol 22:2767–2773PubMed
8.
Zurück zum Zitat Böttcher K, Siewert JR, Roder JD, Busch R, Hermanek P, Meyer HJ (1994) Risiko der chirurgischen Therapie des Magencarcinoms in Deutschland. Chirurg 65:298–306PubMed Böttcher K, Siewert JR, Roder JD, Busch R, Hermanek P, Meyer HJ (1994) Risiko der chirurgischen Therapie des Magencarcinoms in Deutschland. Chirurg 65:298–306PubMed
9.
Zurück zum Zitat Isozaki H, Okajima K, Ichinona T, Hara H, Fujii K, Nomura E (1997) Risk factors of esophagojejunal anastomotic leakage after total gastrectomy for gastric cancer. Hepatogastroenterology 44:1509–1512PubMed Isozaki H, Okajima K, Ichinona T, Hara H, Fujii K, Nomura E (1997) Risk factors of esophagojejunal anastomotic leakage after total gastrectomy for gastric cancer. Hepatogastroenterology 44:1509–1512PubMed
10.
Zurück zum Zitat Lang H, Piso P, Stukenborg C, Raab R, Jahne J (2000) Management and results of proximal anastomotic leaks in a series of 1114 total gastrectomies for gastric carcinoma. Eur J Surg Oncol 26:168–171CrossRefPubMed Lang H, Piso P, Stukenborg C, Raab R, Jahne J (2000) Management and results of proximal anastomotic leaks in a series of 1114 total gastrectomies for gastric carcinoma. Eur J Surg Oncol 26:168–171CrossRefPubMed
11.
Zurück zum Zitat Panieri E, Dent DM (2003) Implications of anastomotic leakage after total gastrectomy for gastric carcinoma. S Afr J Surg 41:66–69PubMed Panieri E, Dent DM (2003) Implications of anastomotic leakage after total gastrectomy for gastric carcinoma. S Afr J Surg 41:66–69PubMed
12.
Zurück zum Zitat Schardey HM, Joosten U, Finke U, Staubach KH, Heiss A, Kooistra A, Rau HG, Nibler R, Ludeling S, Unertl K, Ruckdeschel G, Exner H, Schildberg FW (1997) The prevention of anastomotic leakage after total gastrectomy with local decontamination. A prospective, randomized, double-blind, placebo-controlled multicenter trial. Ann Surg 225:172–180CrossRefPubMed Schardey HM, Joosten U, Finke U, Staubach KH, Heiss A, Kooistra A, Rau HG, Nibler R, Ludeling S, Unertl K, Ruckdeschel G, Exner H, Schildberg FW (1997) The prevention of anastomotic leakage after total gastrectomy with local decontamination. A prospective, randomized, double-blind, placebo-controlled multicenter trial. Ann Surg 225:172–180CrossRefPubMed
13.
Zurück zum Zitat Schardey HM, Kramling HJ, Cramer C, Kusenack U, Hadersbeck J, Schildberg FW (1998) Risk factors and pathogenic microorganisms in patients with insufficient esophagojejunostomy after gastrectomy. Zentralbl Chir 123:46–52 Schardey HM, Kramling HJ, Cramer C, Kusenack U, Hadersbeck J, Schildberg FW (1998) Risk factors and pathogenic microorganisms in patients with insufficient esophagojejunostomy after gastrectomy. Zentralbl Chir 123:46–52
14.
Zurück zum Zitat Seufert RM, Schmidt-Matthiesen A, Beyer A (1990) Total gastrectomy and oesophagojejunostomy—a prospective randomized trial of hand-sutured versus mechanically stapled anastomoses. Br J Surg 77:50–52PubMed Seufert RM, Schmidt-Matthiesen A, Beyer A (1990) Total gastrectomy and oesophagojejunostomy—a prospective randomized trial of hand-sutured versus mechanically stapled anastomoses. Br J Surg 77:50–52PubMed
15.
Zurück zum Zitat Yasuda K, Shiraishi N, Adachi Y, Inomata M, Sato K, Kitano S (2001) Risk factors for complications following resection of large gastric cancer. Br J Surg 88:873–877CrossRefPubMed Yasuda K, Shiraishi N, Adachi Y, Inomata M, Sato K, Kitano S (2001) Risk factors for complications following resection of large gastric cancer. Br J Surg 88:873–877CrossRefPubMed
16.
Zurück zum Zitat Zilling T, Olseen P, Walther BS (1997) Prediction of hospital stay after total gastrectomy. Anticancer Res 17:1355–1359PubMed Zilling T, Olseen P, Walther BS (1997) Prediction of hospital stay after total gastrectomy. Anticancer Res 17:1355–1359PubMed
17.
Zurück zum Zitat Meyer L, Steinert R, Nowak L, Gellert K, Ludwig K, Saeger D, Gastinger I, Lippert H (2005) Prospektive Multizenterstudie zur Chirurgie des Magenkarzinoms—ein Beitrag zur klinischen Versorgungsforschung. Zentralbl Chir 130:97–105CrossRefPubMed Meyer L, Steinert R, Nowak L, Gellert K, Ludwig K, Saeger D, Gastinger I, Lippert H (2005) Prospektive Multizenterstudie zur Chirurgie des Magenkarzinoms—ein Beitrag zur klinischen Versorgungsforschung. Zentralbl Chir 130:97–105CrossRefPubMed
18.
Zurück zum Zitat Hansson LE, Ekstrom AM, Bergstrom R, Nyren O (2000) Surgery for stomach cancer in a defined Swedish population: current practices and operative results. Swedish Gastric Cancer Study Group. Eur J Surg 166:787–795CrossRefPubMed Hansson LE, Ekstrom AM, Bergstrom R, Nyren O (2000) Surgery for stomach cancer in a defined Swedish population: current practices and operative results. Swedish Gastric Cancer Study Group. Eur J Surg 166:787–795CrossRefPubMed
19.
Zurück zum Zitat Markus B, Pinter G (2001) Partial versus total gastrectomy in the surgical treatment of stomach cancer. Magy Seb 54:361–367PubMed Markus B, Pinter G (2001) Partial versus total gastrectomy in the surgical treatment of stomach cancer. Magy Seb 54:361–367PubMed
20.
Zurück zum Zitat Meyer Ch, Lozach P, Rohr S, Topar P, Youssef C, French Association of Surgery (2002) Gastric cancer: the French survey. Acta Gastroenterol Belg 65:161–165PubMed Meyer Ch, Lozach P, Rohr S, Topar P, Youssef C, French Association of Surgery (2002) Gastric cancer: the French survey. Acta Gastroenterol Belg 65:161–165PubMed
21.
Zurück zum Zitat Seulin P, Carrere N, Bloom E, Pradere B, Tap G, Gouzi JL (2000) Stomach cancer: have changes in surgical strategy influenced the results? 20-Year retrospective study. Ann Chir 125:131–136CrossRefPubMed Seulin P, Carrere N, Bloom E, Pradere B, Tap G, Gouzi JL (2000) Stomach cancer: have changes in surgical strategy influenced the results? 20-Year retrospective study. Ann Chir 125:131–136CrossRefPubMed
22.
Zurück zum Zitat Bozzetti F, Gavazzi C, Miceli R, Rossi N, Mariani L, Cozzaglio L, Bonfanti G, Piacenza S (2000) Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial. J Parenter Enteral Nutr 24:7–14 Bozzetti F, Gavazzi C, Miceli R, Rossi N, Mariani L, Cozzaglio L, Bonfanti G, Piacenza S (2000) Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial. J Parenter Enteral Nutr 24:7–14
23.
Zurück zum Zitat Braga M, Gianotti L, Radaelli G, Vignali A, Mari G, Gentilini O, Di Carlo V (1999) Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. Arch Surg 134:428–433CrossRefPubMed Braga M, Gianotti L, Radaelli G, Vignali A, Mari G, Gentilini O, Di Carlo V (1999) Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. Arch Surg 134:428–433CrossRefPubMed
24.
Zurück zum Zitat Ikeda K, Kimura Y, Iwaya T, Aoki K, Otsuka K, Nitta H, Ogawa M, Sato N, Ishida K, Saito K (2004) Perioperative nutrition for gastrointestinal surgery. Nippon Geka Gakkai Zasshi 105:218–222PubMed Ikeda K, Kimura Y, Iwaya T, Aoki K, Otsuka K, Nitta H, Ogawa M, Sato N, Ishida K, Saito K (2004) Perioperative nutrition for gastrointestinal surgery. Nippon Geka Gakkai Zasshi 105:218–222PubMed
25.
Zurück zum Zitat Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V (2002) A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 122:1763–1770PubMed Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V (2002) A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 122:1763–1770PubMed
26.
Zurück zum Zitat Zazzo JF (2004) Preoperative screening and nutritional support of nutritional deficiencies. Ann Chir 129:323–331CrossRefPubMed Zazzo JF (2004) Preoperative screening and nutritional support of nutritional deficiencies. Ann Chir 129:323–331CrossRefPubMed
Metadaten
Titel
Insufficiency risk of esophagojejunal anastomosis after total abdominal gastrectomy for gastric carcinoma
verfasst von
L. Meyer
F. Meyer
H. Dralle
M. Ernst
H. Lippert
I. Gastinger
East German Study Group for Quality Control in Operative Medicine and Regional Development in Surgery
Publikationsdatum
01.11.2005
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 6/2005
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-005-0575-2

Weitere Artikel der Ausgabe 6/2005

Langenbeck's Archives of Surgery 6/2005 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.